Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 6Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Melanoma 2Lung Neoplasms 2Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Nervous System Neoplasms 1Locally Advanced Rectal Cancer 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Central Nervous System Diseases 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Metastases From Non-small Cell Lung Cancer 1Brain Diseases 1Advanced Solid Tumors 1

Interventions

veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Brain Metastases From Non-small Cell Lung Cancer × veliparib × Clear all
NCT01657799 2018-06-06

Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer

AbbVie

Phase 2 Completed
307 enrolled 15 charts
Thoracic

Brain Metastases From Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡